Roche’s tocilizumab cuts deaths in hospitalized COVID-19 patients — study
- For every 25 patients treated with tocilizumab, one additional life is saved
- The UK's RECOVERY trials have unearthed a number of cost-effective treatments to tackle Covid-19's symptoms